About

Company Overview

"Comprehensive Cancer Profiling with ONE Blood"

BeyondDx is a precision medical company established in August 2023 with the goal of "Comprehensive Cancer Profiling with ONE Blood."

Our commitment to precision medicine goes beyond conventional approaches. With UNIQUE iDXGate Solution, we unlock a wealth of invaluable insights, enabling clinicians to delve deeper into the intricacies of each patient's condition.

In recent times, the paradigm of the medical field has shifted towards precision medicine, which involves analyzing the clinical information of individual patients to diagnose and treat diseases. This transformation has led to increased attention to liquid biopsy as a promising approach. However, there are still many limitations to overcome. Our proposed "iDXGate Solution" will be a powerful innovation that addresses these challenges and establishes liquid biopsy as a solution for early detection and treatment of cancer, as well as predicting patient outcomes.

Join us in our mission to go beyond traditional diagnostics, beyond conventional treatments, and beyond the confines of cancer. Together, we can pave the way to a future where precision medicine reigns supreme, and every patient receives the personalized care they deserve.